PLMA_1170x120_9-1-21

AllianceRx Walgreens Prime

AllianceRx Walgreens Prime’s home delivery pharmacy earns URAC reaccreditation

AllianceRx Walgreens Prime’s home delivery pharmacy earns URAC reaccreditation

ORLANDO, Fla. — AllianceRx Walgreens Prime has received Mail Service Pharmacy reaccreditation from URAC for its home delivery pharmacy services. URAC is an independent organization focused on promoting health care quality through leadership, accreditation, measurement, and innovation. URAC’s full accreditation status means AllianceRx Walgreens Prime’s home delivery is meeting industry-leading standards of organizational quality, customer service, communications, drug utilization and pharmacy

AllianceRx Walgreens Prime connects patients to $600M financial assistance

AllianceRx Walgreens Prime connects patients to $600M financial assistance

ORLANDO, Fla. — Specialty medications – those used to treat patients with rare diseases or chronic conditions – can be expensive. That is why AllianceRx Walgreens Prime – one of the largest specialty and home delivery pharmacies in the U.S. – has dedicated team members who provide information on financial assistance programs available to eligible patients. Over

HIV medicines among latest hard-to-find drugs available through AllianceRx Walgreens Prime

HIV medicines among latest hard-to-find drugs available through AllianceRx Walgreens Prime

ORLANDO, Fla. — Cabenuva (cabotegravir/rilpivrine), the first and only once-monthly complete injectable treatment is available through AllianceRx Walgreens Prime for adults living with human immunodeficiency virus type 1 (HIV-1). Manufactured for ViiV Healthcare by GlaxoSmithKline, Cabenuva provides an alternative to patients who relied on a daily oral treatment regimen. HIV is a virus that attacks the body’s immune system.

AllianceRx Walgreens Prime, Highmark launch social determinants of health pilot

AllianceRx Walgreens Prime, Highmark launch social determinants of health pilot

ORLANDO, Fla. — Helping improve patient outcomes by identifying and removing barriers to their care is just one reason AllianceRx Walgreens Prime and Highmark Inc. have joined forces to launch a social determinants of health (SDOH) pilot outreach program. The pilot will kick off with Highmark insurance members who have a multiple sclerosis (MS) diagnosis and use AllianceRx Walgreens

Study affirms oral disease-modifying therapies are well tolerated with high medication adherence rates

Study affirms oral disease-modifying therapies are well tolerated with high medication adherence rates

ORLANDO, Fla. — A recent study of patients receiving oral FDA-approved therapies used to treat relapsing forms of multiple sclerosis (MS) revealed high tolerance, low rates of adverse drug events, and similar medication adherence rates across all study medications. The retrospective study was conducted by AllianceRx Walgreens Prime, a leading specialty and home delivery pharmacy, in conjunction with Duquesne

AllianceRx Walgreens Prime adds 4 cancer drugs to portfolio

AllianceRx Walgreens Prime adds 4 cancer drugs to portfolio

ORLANDO, Fla.—  AllianceRx Walgreens Prime is helping cancer patients prepare for challenges through multidisciplinary, holistic patient care, including access to more than 60 limited distribution oncology drugs. Most recently, Pfizer added to this list by granting the specialty pharmacy access to four targeted cancer therapies that treat metastatic melanoma, metastatic colorectal cancer, and two types

Kesimpta available through AllianceRx Walgreens Prime

Kesimpta available through AllianceRx Walgreens Prime

ORLANDO, Fla. —  Kesimpta (ofatumumab), the first and only self-administered, targeted B-cell therapy for patients with relapsing forms of multiple sclerosis (MS) in adults, is available through AllianceRx Walgreens Prime. MS is a rare disease of the central nervous system that affects nearly 1 million people in the United States, according to the National MS Society. MS disrupts the flow of information

AllianceRx Walgreens Prime cancer patients can manage care online with new digital tool

AllianceRx Walgreens Prime cancer patients can manage care online with new digital tool

ORLANDO, Fla. – Cancer patients who self-administer their therapy can now better manage their care online, thanks to the latest digital clinical assessment available only through AllianceRx Walgreens Prime. The newly-released self-serve tool simplifies patients’ online experiences when refilling their prescriptions. Earlier this year, AllianceRx Walgreens Prime announced the release of clinical assessments available for patients

AllianceRx Walgreens Prime named exclusive distributor for HRA Pharma Rare Diseases

AllianceRx Walgreens Prime named exclusive distributor for HRA Pharma Rare Diseases

ORLANDO — HRA Pharma Rare Diseases has named AllianceRx Walgreens Prime – one of the largest specialty and home delivery pharmacies in the United States – as the exclusive specialty pharmacy and clinical support provider for two of its rare disease drugs, Lysodren and Metopirone. Lysodren (mitotane) is the only FDA-approved drug to treat inoperable, functional or

AllianceRx Walgreens Prime offers digital clinical assessments

AllianceRx Walgreens Prime offers digital clinical assessments

ORLANDO, Fla. — Patients with chronic or complex conditions can better manage their care online, thanks to new digital clinical assessments available only through AllianceRx Walgreens Prime. In the wake of the global pandemic, the nation’s third largest specialty and home delivery pharmacy fast-tracked the release of these tools to simplify patients’ online experience when

Rick Miller receives NASP Distinguished Service Award

Rick Miller receives NASP Distinguished Service Award

ORLANDO, Fla. — The National Association of Specialty Pharmacy (NASP) has bestowed upon Rick Miller, vice president of clinical and professional services at AllianceRx Walgreens Prime, the Distinguished Service Award at the opening general session of its 2020 annual meeting. The Distinguished Service Award is given to the individual who has made a sustained contribution to

Inqovi now available through AllianceRx Walgreens Prime

Inqovi now available through AllianceRx Walgreens Prime

ORLANDO, Fla. — Adults with certain types of rare blood cancers can now receive their treatment in the comfort of their own home, thanks to a new medication available through a limited distribution with AllianceRx Walgreens Prime. Inqovi (decitabine and cedazuridine), manufactured by Taiho Oncology, treats adult patients with myelodysplastic syndromes (MDS) (a type of blood cancer) and

AllianceRx Walgreens Prime unveils new patented process for delivering specialty medicine

AllianceRx Walgreens Prime unveils new patented process for delivering specialty medicine

ORLANDO, Fla. — A new patented process for delivering specialty medicine will assure AllianceRx Walgreens Prime patients receive their medicine delivered at the correct temperature. AllianceRx Walgreens Prime, one of the nation’s largest specialty and home delivery pharmacies, will exclusively use the patent – held by parent company Walgreens – to help increase patient safety, improve patient

AllianceRx Walgreens Prime to distribute Vyepti

AllianceRx Walgreens Prime to distribute Vyepti

ORLANDO, Fla. — Lundbeck, a global pharmaceutical company specializing in brain diseases, has named AllianceRx Walgreens Prime one of only two specialty pharmacies to distribute its newest medication for the preventive treatment of migraine in adults. The medication, Vyepti (eptinezumab-jjmr), is the first and only intravenous preventive treatment for migraine. Migraine is a complex and incapacitating neurological

1 2 3